Navigation Links
New White Paper from My Gene Counsel Releases Data on Frequency of Medical Guideline Revisions and Offers Solutions for Keeping Patients and Providers Informed

My Gene Counsel, a digital health company that provides personalized, easy-to-understand, web-based genetic counseling information, has published a new white paper that explores how frequently medical management guidelines have been updated over a five year period and provides guidance as to how patients and medical providers can be kept informed as changes are made.

Entitled “How Often Do Medical Management Guidelines Change for People with Germline Genetic Findings? A Solution for Keeping Patients and Providers Updated,” the paper is based on research conducted by My Gene Counsel using the American College of Medical Genetics and Genomics (ACMG) SFv2.0 list of 59 genes as a proxy for medically actionable genetic conditions. Overall, My Gene Counsel found a total of 623 revisions, which is further broken down in the report by gene, disease category, and disease subcategory.

“Genetic testing can be lifesaving, but it must come with all the facts,” said Ellen Matloff, president and CEO of My Gene Counsel. “Most people who have genetic testing never see a genetics specialist. If they do, it’s once or twice and then never again. However, the field is changing all the time. For the average health care provider, the challenge of keeping up-to-date and informing patients is insurmountable.”

Given the frequency of medical management updates found, the white paper examines the need for an automated, scalable method for keeping pace with the growing demand for the latest genomic information. My Gene Counsel presents a viable solution for collating, tracking, and delivering digital genetic updates to patients, providers, and health systems at scale in a timely and responsible manner.

“Health care consumers must have access to the newest management recommendations so they can achieve better health outcomes using fewer precious resources,” said Meagan Farmer, lead author and genetic counseling business manager for My Gene Counsel. “Forward-thinking health systems and insurers are looking for tools that leverage technology, such as My Gene Counsel, that will deliver these benefits to their provider and patient networks over time.”

My Gene Counsel’s white paper can be downloaded at

About My Gene Counsel:
My Gene Counsel is a digital health company that provides easy-to-understand, web-based genetic counseling reports to health care consumers directly or through enterprise partners. The company is the only genetics resource used in the market today that is designed for digital and mobile access, is available 24/7/365, and delivers comprehensive content created by medical experts and patient advocates. Their result-specific solution provides genetic guidance that updates as research and critical new information emerges. For more information, visit

Read the full story at

Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved

Related biology technology :

1. R3 Stem Cell Announces Addition of World Renowned Exosome Expert Dr. Ian White to Training Course
2. Drs. Steven White and Brad Haines Treat Gum Disease in Mooresville, NC with Precise Laser Dentistry
3. AMRI’s Whitehouse Laboratories Increases Testing Resources Dedicated to USP 661.1 and 661.2 Packaging Qualification
4. Whitehouse Labs Expands Capabilities For ISO 80369 Testing
5. Whitehouse Laboratories Recommends Early Adoption of USP 661 Guidelines to Enhance Packaging Safety and Stability
6. Whitehouse Labs To Showcase Capabilities At MD&M East: June 13-15, 2017
7. SSCI and Whitehouse Laboratories to Exhibit at Interphex 2017
8. ProMIS Neurosciences issues white paper entitled “Results from recent Alzheimer’s disease trials validate the ProMIS approach”
9. Whitehouse Laboratories to Co-Present with Novo Nordisk at PDA Parenteral Packaging Conference
10. Whitehouse Labs Increases Focus and Expertise In Extractables & Leachables
11. Attagene Receives Tibbetts Award at White House Ceremony
Post Your Comments:
(Date:12/4/2019)... ... December 04, 2019 , ... Improved Pharma’s analytical methods ... materials. Additionally, their PDF Synchrotron methods provide a way to determine the structure ... in regulatory and patent applications.  , The latest developments were recently shared at ...
(Date:11/22/2019)... , ... November 22, 2019 ... ... engineering firm, hosted a live webinar covering a step-by-step cold chain validation ... antibody-drug conjugates, and cell therapies. Targeting complex cold chain biopharmaceutical industry leaders, ...
(Date:11/12/2019)... ... November 12, 2019 , ... REPROCELL Inc. a ... selected by Lantern Pharma to provided preclinical screening and drug sensitivity for its ... points using panels of unique and genetically edited cell lines from various tumors. ...
(Date:11/12/2019)... ... November 12, 2019 , ... ... to educate Americans about the deadly healthcare-associated infection C. diff. The campaign, ... of the epidemic, which kills at least 30,000 people in the U.S. each ...
Breaking Biology Technology:
(Date:11/27/2019)... ... , ... The MyOnyx rehab solution by Thought ... measure and display muscle activity in real time. This information helps the physical ... patient and therapist can see when exercises are performed correctly and efficiently. , ...
(Date:11/19/2019)... ... 19, 2019 , ... The inaugural Cell & Gene Therapy Day takes place ... one-day event will be chaired by Dr Aiman Shalabi, VP R&D, Cell and Gene ... “We are witnessing significant innovation in cell and gene therapies, and we are at ...
(Date:11/12/2019)... ... November 12, 2019 , ... ... in the design and manufacturer of technical ergonomic seating solutions, announced this ... compliant with Healthier Hospital Initiative guidelines. Established by Practice Greenhealth, a health ...
Breaking Biology News(10 mins):